Erweiterte Suche

Philippe Petitcolin is currently the Chairman-Supervisory Board at Diot SAS and SIACI Saint Honoré SASU.

Philippe Petitcolin ist eine Unternehmerpersönlichkeit, die an der Spitze von 12 verschiedenen Unternehmen stand und derzeit die Position des Chairman bei KNDS und des Chairman & Chief Executive Officer für Dictao SA innehat. Er ist auch im Verwaltungsrat von Lectricit de France SA, Safran SA (ehemaliger Chief Executive Officer & Director), Belcan LLC und SUEZ SA. Herr Petitcolin war zuvor Chairman von Morphotrak LLC, Chairman für Safran Electronics & Defense SAS, Export Manager bei Europrim SCI, Sales Director für Chester Cable Corp, Chairman und Chief Executive Officer bei SNECMA SA, Chairman und Chief Executive Officer bei Labinal SA, Chairman und Chief Executive Officer bei Sagem Dfense Scurit SAS, Chairman bei Safran Identity & Security SAS, Chairman bei Morpho Detection International, Inc. und Chief Executive Officer bei Morpho USA, Inc. sowie Chief Executive Officer bei Safran Filtration Systems, Area Manager bei Alcatel Cable SA und Export Director bei Alcatel Cable SA. Er erhielt einen Undergraduate-Abschluss und einen Graduate-Abschluss vom Centre de Perfectionnement aux Affaires.

David Petitcolin worked as a Portfolio Manager at Principal Global Investors (Europe) Ltd.
from 2013 to 2018.
He then worked as a Strategist at Deutsche Bank AG (Broker UK) from 2018 to 2020.
Prior to that, he worked as a Global Currency Strategist at NatWest Markets Plc (Broker) from 2010 to 2013.

Philippe Matsumoto is currently working as Treasurer & Managing Director at BlackRock, Inc. He is also working as a Director at BlackRock UK (Sigma) Ltd., BlackRock UK (Alpha) Ltd., and BlackRock UK (Gamma) Ltd.
His former job was as Treasurer at Euronext NV.

Philippe Deschamps is an Independent Director at Coeptis Therapeutics Holdings, Inc. He previously served as the Chairman, President & Chief Executive Officer at Helius Medical Technologies, Inc. from 2012 to 2020.
Prior to that, he was the President & Chief Executive Officer at GSW Worldwide from 2002 to 2011.
Philippe also held the position of Chief Executive Officer at MediMedia LLC in 2012 and President & Chief Executive Officer at Helius Medical, Inc. from 2013 to 2014.
He is currently serving as the President, Chief Executive Officer & Director at ChitogenX, Inc. from 2022 to 2024.
Philippe's earlier experience includes working as the Director-Neuroscience Marketing at Bristol Myers Squibb Co. from 1995 to 1998.
He is also a Senior Advisor at PTV Sciences LP.
Philippe completed his undergraduate degree from the University of Ottawa in 1985.

Philippe Million-Rousseau is Manager Director of Kotio SA. Prior to that, he held various positions at Unisys Corp., Télésystèmes and SEDIT Marianne SA. Mr. Million-Rousseau received a degree from Ecole Supérieure de Commerce de Paris.